Ciprofloxacin vs Pembrolizumab

Ciprofloxacin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Ciprofloxacin and Pembrolizumab.

Mechanism of Action

Ciprofloxacin: Inhibits bacterial DNA gyrase and topoisomerase IV.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Ciprofloxacin — 4 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Ciprofloxacin — C17H18FN3O3.

Molecular Weight: Ciprofloxacin — 331.3460 g/mol.

Type: Ciprofloxacin — Small molecule; Pembrolizumab — Antibody.